These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
38 related items for PubMed ID: 1829837
21. Treatment of rats with glucagon, vasointestinal peptide or secretin has a different effect on bilirubin and p-nitrophenol UDP-glucuronyltransferase. Ricci GL, Fevery J. Biochem Pharmacol; 1988 Sep 15; 37(18):3526-8. PubMed ID: 3139000 [No Abstract] [Full Text] [Related]
23. Inhibition of replication and differentiation in malignant mouse neuroblasts. Byfield JE, Karlsson U. Cell Differ; 1973 Mar 15; 2(1):55-64. PubMed ID: 4798238 [No Abstract] [Full Text] [Related]
24. In vitro demonstration of an endothelial proliferative factor produced by neural cell lines. Suddith RL, Kelly PJ, Hutchison HT, Murray EA, Haber B. Science; 1975 Nov 14; 190(4215):682-4. PubMed ID: 171768 [Abstract] [Full Text] [Related]
25. Preliminary observations on the in vitro toxicity of N-butylbenzenesulfonamide: a newly discovered neurotoxin. Nerurkar VR, Wakayama I, Rowe T, Yanagihara R, Garruto RM. Ann N Y Acad Sci; 1993 May 28; 679():280-7. PubMed ID: 8512189 [No Abstract] [Full Text] [Related]
26. The quiescent centre in excised roots of Pisum sativum L. MacLeod RD, Scadeng DW. Protoplasma; 1975 May 28; 86(1-3):135-40. PubMed ID: 1197770 [No Abstract] [Full Text] [Related]
27. Further studies on the interaction between vasoactive intestinal peptide and neuroblastoma cell lines. Pence JC, Shorter NA. Prog Clin Biol Res; 1991 May 28; 366():375-81. PubMed ID: 1829837 [No Abstract] [Full Text] [Related]
30. Retinoic acid resistant neuroblastoma cells and the expression of insulin-like growth factor-II. Gaetano C, Matsumoto K, Thiele CJ. Prog Clin Biol Res; 1991 May 28; 366():165-72. PubMed ID: 2068136 [No Abstract] [Full Text] [Related]
31. Transactivation of HER2 by vasoactive intestinal peptide in experimental prostate cancer: Antagonistic action of an analog of growth-hormone-releasing hormone. Sotomayor S, Carmena MJ, Schally AV, Varga JL, Sánchez-Chapado M, Prieto JC, Bajo AM. Int J Oncol; 2007 Nov 28; 31(5):1223-30. PubMed ID: 17912451 [Abstract] [Full Text] [Related]
32. Further studies on the interaction between vasoactive intestinal peptide and neuroblastoma cell lines. Pence JC, Shorter NA. Prog Clin Biol Res; 1991 Nov 28; 366():375-81. PubMed ID: 1829837 [No Abstract] [Full Text] [Related]
34. Effects of secretin and gastric inhibitory polypeptide on human pancreatic growth hormone-releasing factor(1-40)-stimulated growth hormone levels in the rat. Murphy WA, Lance VA, Sueiras-Diaz J, Coy DH. Biochem Biophys Res Commun; 1983 Apr 29; 112(2):469-74. PubMed ID: 6405744 [Abstract] [Full Text] [Related]
36. Transactivation of HER2 by vasoactive intestinal peptide in experimental prostate cancer: Antagonistic action of an analog of growth-hormone-releasing hormone. Sotomayor S, Carmena MJ, Schally AV, Varga JL, Sánchez-Chapado M, Prieto JC, Bajo AM. Int J Oncol; 2007 Nov 29; 31(5):1223-30. PubMed ID: 17912451 [Abstract] [Full Text] [Related]